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Abstract
Skeletal muscle has a remarkable ability to respond to different physical stresses. Loading muscle 
through exercise, either anaerobic or aerobic, can lead to increases in muscle size and function 
while, conversely, the absence of muscle loading stimulates rapid decreases in size and function. 
A principal mediator of this load-induced change is focal adhesion kinase (FAK), a downstream 
non-receptor tyrosine kinase that translates the cytoskeletal stress and strain signals transmitted 
across the cytoplasmic membrane by integrins to activate multiple anti-apoptotic and cell growth 
pathways. Changes in FAK expression and phosphorylation have been found to correlate to 
specific developmental states in myoblast differentiation, muscle fiber formation and muscle size 
in response to loading and unloading. With the capability to regulate costamere formation, 
hypertrophy and glucose metabolism, FAK is a molecule with diverse functions that are important 
in regulating muscle cell health.
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Introduction
Skeletal muscle is a remarkably plastic tissue that is capable of responding to changes in 
muscle workload. The ability of the muscle to detect changes in cytoskeletal tension and 
initiate the appropriate signal is the responsibility of proteins that detect cytoskeletal tension, 
termed mechanosensors. Mechanosensors relay the information throughout the muscle cell 
to change gene transcription and protein expression. Skeletal muscle contains multiple types 
of mechanosensors with diverse responses to changes in tension. Changes in the activity of 
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ion channels and signaling through sarcomeric proteins like titin are the result of changes in 
muscle tension [Reviewed in (Burkholder 2007; Gautel 2011; Tidball 2005)]. This review 
will focus on the role of focal adhesion kinase (FAK), a prominent and well-studied protein 
that responds to changes in cellular tension. FAK is a 125 kDa non-receptor tyrosine kinase 
that lies within and coordinates signals through a multiprotein complex called the focal 
adhesion complex (Schaller et al. 1995). Focal adhesion complexes anchor the cytoplasmic 
tails of heterodimeric membrane-spanning proteins called integrins, forming a continuous 
link between the cytosol and extracellular matrix (ECM) (Hanks et al. 2003). FAK is similar 
to proline-rich tyrosine kinase [Pyk2; also commonly referred to as FAK2, protein tyrosine 
kinase 2-beta (PTK2β), cell-associated kinase-beta (CAK-β) or calcium-dependent tyrosine 
kinase (CADTK)] in amino acid sequence, structure and substrates. However, their cellular 
functions are distinct with Pyk2 being highly cell-specific and its activation being 
independent of ECM and integrin interactions, which are most likely the main activator of 
FAK in skeletal muscle (Orr and Murphy-Ullrich 2004). FAK also has similar qualities to 
integrin-linked kinase (ILK), an important component of the focal adhesion complex. The 
role of ILK in skeletal muscle is largely unknown but it has been demonstrated to respond 
positively in skeletal muscle following overload (Chaillou et al. 2013) and transgenic 
integrin overexpression (Boppart et al. 2011). Furthermore, muscle-specific HSACre-driven 
ILK knockout resulted in decreased hypertrophic intracellular signaling, myotendinous 
junction organization and insulin receptor stability (Wang et al. 2008).
In skeletal muscle, the focal adhesion complex is densely localized within the costamere 
(Anastasi et al. 2008; Bloch and Gonzalez-Serratos 2003) and myotendinous junction 
(Burkin and Kaufman 1999; Mayer et al. 1997), which are the main force transducers of 
skeletal muscle. The costamere, composed of the dystroglycan and focal adhesion complex 
(Bloch and Gonzalez-Serratos 2003), transmits sarcomeric forces laterally to the 
extracellular matrix, while the myotendinous junction transmits forces longitudinally 
through the tendon to bone. Since integrins have no known kinase activity, they must rely on 
the focal adhesion complex, primarily through FAK, to signal changes in cytoskeletal 
loading.
FAK has multiple roles within skeletal muscle. It is activated by receptor tyrosine kinases 
for growth factors, such as insulin (Bisht et al. 2007) and insulin-like growth factor-1 
(IGF-1) (Crossland et al. 2013) and can regulate myoblast development and muscle fiber 
formation (Quach et al. 2009). The latter function is intriguing because the convergence of 
myogenesis, nutritional control of muscle homeostasis and muscle loading provide a 
meeting point between prominent hypertrophy and anti-apoptotic signals that reinforce the 
importance of FAK signaling during muscle development and homeostasis.
Regulation of FAK activation
The following is a brief summary of the structure and autoregulation of FAK that is meant to 
provide basic structural information for the reader. For more detailed reviews, please refer to 
(Frame et al. 2010; Hall et al. 2011; Parsons 2003). The structure of FAK (Fig. 1) shares 
characteristics of other focal adhesion complex and membrane-bound proteins, such as talin. 
FAK is composed of three major domains: an N-terminal 4.1 ezrin, radixin, moesin (FERM) 
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domain, a kinase domain and the C-terminal focal adhesion targeting (FAT) domain 
(Parsons 2003). The FERM domain targets and organizes proteins to the cell membrane 
(Baines et al. 2014) and is a major regulator of FAK activity. Deletion of the initial 375 
residues of the FAK FERM domain leads to a constitutively active enzyme (Cooper et al. 
2003). Additionally, the FERM domain of FAK can bind to the cytoplasmic portion of the 
β1 integrin tail (Schaller et al. 1995), creating a logical docking point to stabilize or signal 
through the focal adhesion complex. A linker domain, which contains the major 
phosphorylation site at tyrosine 397, connects the FERM domain and kinase domain. The 
kinase domain contains two tyrosine residues that are important for optimal FAK function, 
tyrosines 576 and 577 (Schaller et al. 1994). The FAT domain’s main responsibility is 
directing FAK to the focal adhesion complex (Hildebrand et al. 1993). FAK-related non-
kinase (FRNK) is a protein transcribed from the FAT portion of the FAK gene (PTK2) and 
acts to inhibit FAK in many cell types, including skeletal muscle (Klossner et al. 2013).
Lietha and colleagues (Lietha et al. 2007) were able to crystallize an autoinhibited form of 
FAK and describe the mechanisms that block kinase activity in the inactive form of FAK. 
The structure of the autoinhibited enzyme showed binding of the FERM domain to the 
kinase domain, essentially burying the linker that contains tyrosine 397. The location of the 
FERM domain during this interaction also protects the important tyrosines of the kinase 
domain, tyrosines 576 and 577, from phosphorylation (Lietha et al. 2007). Movement of the 
FERM domain allows tyrosine 397 to become exposed to the cytosol, after which it is 
quickly autophosphorylated (Schaller et al. 1994). What exactly causes the initial shift in the 
FERM domain is unknown but there is evidence that acidic phospholipids such as 
phosphatidylinositol 4,5-bisphosphate can induce a change in the position of FERM and 
thereby activate FAK (Cai et al. 2008). Phosphorylation of tyrosine 397 creates high affinity 
binding sites for proteins that contain Src Homology (SH) 2 and 3 domains, including the 
tyrosine kinase, cSrc. cSrc phosphorylates tyrosines 576 and 577 of FAK to fully activate its 
kinase activity (Schaller et al. 1994).
FAK expression and function during muscle development
Muscle development is a coordinated process in which transcription factors like myogenin 
and MyoD induce terminal differentiation of myoblasts. Upon differentiation, these 
myoblasts then fuse together to form multi-nucleated myotubes. In this early form of 
muscle, the ECM and sarcolemmal proteins are important in regulating and coordinating 
proper myogenesis. Since integrins are major effectors of laminin binding and are used to 
stabilize muscle during myogenesis (Burkin and Kaufman 1999), it would be logical that 
FAK would be an important regulator of myoblasts during these states. Indeed, FAK activity 
is necessary for expression of MyoD and other important cell cycle regulators such as Cdo 
and Cdc42 in C2C12 cells (Han et al. 2011).
Myoblast proliferation and differentiation
Differentiation of myoblasts for 3 days activated FAK (Goel and Dey 2002a). However, the 
state of FAK activation can alter cell cycle progression and commitment to differentiation of 
muscle progenitor cells. Ectopically increasing expression of a constitutively active 
membrane-bound wild-type FAK promoted cell proliferation in quail myoblasts while a 
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tyrosine to phenylalanine inactivating mutation of the main activation site of FAK promoted 
differentiation and multinucleated myotube formation (Sastry et al. 1999). Ectopic over-
expression of certain α integrin subunits altered FAK phosphorylation, with the RGD-
sequence binding α5 integrin having no affect on FAK phosphorylation and the laminin-
binding α6 integrin decreasing FAK phosphorylation (Sastry et al. 1999), providing 
evidence that the evolution of the ECM and integrin to which it is bound can alter the state 
of FAK activation in early muscle development. The addition of insulin to myoblasts 
stimulated FAK phosphorylation in proliferating cells but rapidly decreased phosphorylation 
in differentiated muscle cells within 5 min, followed by a gradual increase in 
phosphorylation levels back to near-baseline after 30 min (Goel and Dey 2002a). Expression 
of a dominant-negative FAK in C2C12 myoblasts results in a loss of RhoA-induced α-actin 
promoter activity (Wei et al. 2000), suggesting that the presence of functional FAK is 
necessary for important fundamental gene expression in muscle cells.
The level of FAK activation also responds to cues for differentiation. FAK phosphorylation 
levels decreased when myoblasts were switched from proliferating medium to 
differentiating medium but then gradually increased when cells were maintained in 
differentiation medium for 1–6 days (Clemente et al. 2005; Goel and Dey 2002a). Other 
studies of C2C12 cells found that total FAK decreases gradually during differentiation while 
phosphorylated FAK gradually increases (Nguyen et al. 2014). Similarly, primary myoblasts 
incubated with differentiation media show decreases in total and phosphorylated FAK over 
the course of 96 h (Quach et al. 2009). Clemente et al (2005) localized FAK to lamellipodia 
and filopodia in proliferating myoblasts. However, following 24 h in differentiating 
medium, there were no apparent lamellipodia or filopodia and FAK was localized to large 
patches on the cytoplasmic surface of the cytoplasmic membrane. Transfection of 
differentiating myoblasts with wild-type FAK prevented differentiation-associated decreases 
in the cell cycle regulator cyclin D1 and prevented expression of myogenin mRNA and 
protein. Further, FAK overexpression reduced upregulation of creatine kinase activity 
(Clemente et al. 2005). The decreases in total FAK expression associated with 
differentiation may be due to targeting to the ubiquitin–proteasome pathway for proteolytic 
destruction after ubiquination by the E3 ligase mitsugumin 53 as protein levels decrease 
during differentiation without any change in mRNA levels (Nguyen et al. 2014). In 
regulating the muscle cell cycle, FAK translocation to the nucleus following binding to the 
heterochromatin interacting methyl CpG-binding protein 2 (MBD2) induces myogenin 
expression by decreasing MBD2 protein interactions within the myogenin promoter (Luo et 
al. 2009). In summary, FAK expression and activity are reduced early after the cell commits 
to differentiation and this decrease is critical to correct progression of differentiation. Once 
differentiation programs are initiated, FAK activity is restored, presumably to participate in 
other integrin functions including fusion of myoblasts with each other or with existing 
muscle fibers.
Myoblast fusion
There is evidence that FAK is necessary for proper myoblast fusion. FAK has been shown to 
be expressed at higher levels in myotubes compared to myoblasts (Fluck et al. 1999). 
Satellite cell-specific FAK knock out mice had a fourfold decrease in regenerating fibers 3 
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days after BaCl2-induced injury and inhibition of FAK by its FAT domain or siRNA 
prevented myoblast fusion (Quach et al. 2009). The mechanism behind this appears to be 
decreases in FAK-regulated expression of important myofusion proteins such as the β1D 
integrin and caveolin-3 (59). Furthermore, knockdown of heparan sulfate endosulfatases 
disrupts phosphorylated FAK sarcolemmal localization and can inhibit myoblast fusion 
(Tran et al. 2012).
Costamere formation
FAK has a functional role in costamere synthesis, most likely stabilizing and signaling 
through the protein scaffold around the cytoplasmic portion of integrins. There is no 
evidence that FAK routinely localizes to the dystroglycan complex but integrins have been 
implicated as being critical to proper costamere formation (Balaban et al. 2001; Fujita et al. 
2007) and FAK’s downstream signaling ability makes it a prominent component for 
costamere genesis. During muscle development, costamere formation is delayed compared 
to myofibrillar formation (Quach and Rando 2006), meaning that there has to be a more 
developed myofiber in order for the maturation of the costamere. This is most likely related 
to muscle specific gene expression and the need for some type of contractility in the muscle 
cell to correctly form the costamere and sarcomere (De Deyne 2000; Fujita et al. 2007; 
Quach and Rando 2006). Inhibition of FAK by a dominant-negative FAT or FAK siRNA in 
myotubes resulted in lower levels of costamere organization as measured by 
immunofluorescence of vinculin, the first protein associated with costameres (Pardo et al. 
1983) and a protein that connects the many proteins of the focal adhesion complex (Bloch 
and Gonzalez-Serratos 2003), and myofiber formation (Quach and Rando 2006).
Other proteins that can regulate FAK during development
Protein kinase C (PKC) negatively-regulates FAK phosphorylation and focal adhesion 
complex localization during the differentiation of myoblasts but stimulates FAK 
phosphorylation while in the proliferating stage (Goel and Dey 2002b). PKC increases FAK 
phosphorylation and cell spreading in α5-null myoblasts, suggesting that PKC may work 
through FAK in an inside-out signaling pathway, independent of integrins, which creates 
more ECM binding capabilities for the cell (Disatnik and Rando 1999). PKC-null myoblasts 
have lower levels of phosphorylated FAK and exogenous transfection of PKC increases 
FAK phosphorylation in C2C12 cells (Madaro et al. 2011).
FAK activation can also occur following ligand binding of the neogenin receptor. Neogenin 
is a membrane receptor protein that binds to a family of proteins called netrins that are 
structurally similar to laminin. Netrins are secretory proteins that aid in localizing axons and 
have been shown to be important in other cell types (Lai Wing Sun et al. 2011). In its 
cytosolic tail, neogenin can bind and activate FAK (Li et al. 2004). In mouse embryos that 
had neogenin knocked-out by gene trapping, myotubes were smaller and there was an 
almost complete inhibition of FAK activation (Bae et al. 2009). In non-gene trapped 
myoblasts, recombinant netrin increased FAK phosphorylation after 30 min but neogenin 
knockout myoblasts had no FAK phosphorylation response (Bae et al. 2009).
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FAK and actin dynamics
As mentioned previously, FAK may have a role in actin dynamics (Wei et al. 2000), and in 
muscle, most likely functions through activation of RhoA and downstream signaling through 
FAK and serum response factor (SRF) (Wei et al. 1998). RhoA is a small GTPase that 
works in coordination with the striated muscle activator of Rho signaling (STARS) to help 
regulate the formation of filamentous actin and SRF is a transcription factor that can control 
actin dynamics and many integral proteins of the muscle cell cycle (Lamon et al. 2014). To 
our knowledge, there is no explicit interaction between STARS and FAK in skeletal muscle 
but there is a potential for RhoA-induced FAK regulation. In cardiac muscle tissue, FAK 
activation following cell stretch is dependent on RhoA (Torsoni et al. 2005) and inhibition 
of RhoA with an exoenzyme prevented FAK autophosphorylation (Del Re et al. 2008). In 
skeletal muscle, RhoA protein expression decreases following 3 days of hindlimb unloading 
and increases following reloading (McClung et al. 2004). We have seen RhoA decrease 
similarly to FAK following downhill running (Graham et al. 2015). SRF can colocalize with 
both RhoA and FAK (Sakuma et al. 2003) and unloading decreased SRF protein expression 
along with FAK protein expression in rat hindlimb muscles (Gordon et al. 2001). 
Furthermore, decreased SRF expression is associated with decreased levels of FAK in 
dystrophic muscle (Sakuma et al. 2004). The limited information regarding the 
RhoA/FAK/SRF pathway in muscle suggest that they may have a role in muscle and actin 
regulation but more research is needed to clearly elucidate the function of this pathway.
Cytokine regulation through FAK
The literature is sparse in regards to the ability of cytokine signaling to modulate FAK 
expression or activation in skeletal muscle. Exposing C2C12 cells to exogenous TNFα 
increases FAK expression. Silencing of FAK with siRNA in TNFα-exposed C2C12 cells, or 
an inactivating tyrosine to phenylalanine mutation on the main activation site of FAK, 
decreases IL-6 production, suggesting that FAK participates in the regulation of the 
expression of inflammatory cytokines (Tseng et al. 2010). This concept of IL-6 regulation 
by FAK is intriguing due to the large IL-6 response typically seen after intense exercise 
(Pedersen and Febbraio 2008).
Mechanisms for muscle hypertrophy
FAK and cSrc
Activation of cSrc by FAK has been implicated in the hypertrophy of cardiac muscle 
(Franchini 2012; Torsoni et al. 2003) but evidence is lacking regarding cSrc’s role in 
skeletal muscle. In overloaded cardiac muscle, pressure-related hypertrophy is associated 
with activation of FAK and extracellular signal-related kinase (ERK) 1/2 (Franchini et al. 
2000). Conversely, inhibition of FAK or cSrc decreases ERK1/2 activation following cell 
stretch (Torsoni et al. 2003). In skeletal muscle, ERK1/2 responds to various types of muscle 
loading (Boppart et al. 2001; Hornberger et al. 2005; Williamson et al. 2003) and is 
important for muscle hypertrophy and overall homeostasis (Shi et al. 2009). Thus the 
prospect of a FAK/cSrc/ERK1/2 relationship warrants investigation. Cyclic strain decreases 
phosphorylation of cSrc at tyrosine 527, the main inhibitory site on this kinase, thus 
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activating cSrc; this effect is maintained for 60 min in cultured C2C12 (Kumar et al. 2004). 
We have observed that in rat soleus, total and activated cSrc protein expression are not 
affected by 90 min of eccentric downhill running at 2 and 48 h post-exercise despite 
decreases in FAK levels (Graham et al. 2015) We have also found that cSrc activation is 
decreased 56 days following spinal cord injury (SCI) in rat gastrocnemius with no changes 
in total or activated ERK1/2 (Graham, manuscript in review). This suggests that in skeletal 
muscle, direct FAK and cSrc signaling through ERK1/2 may occur (1) less than 2 h 
following exercise; (2) during the immediate time-frame following unloading or paralysis 
or; (3) independently of ERK1/2 in load-induced cell signaling.
The FAK/PI3K/Akt pathway
In skeletal muscle it is likely that there is cross-talk between FAK and the 
phosphatidylinosital-3 kinase (PI3K) pathway (Fig. 2). The PI3K pathway includes Akt, 
mechanistic target of rapamycin (mTOR) and p70S6 kinase (p70S6k). mTOR is a protein 
kinase and serves as a master controller of cell size and protein synthesis (Reiling and 
Sabatini 2006). Its activity responds to many signals that include nutritional changes, growth 
factors and changes in muscle loading (Baar and Esser 1999; Baar et al. 2006; Bodine 2006; 
Goodman et al. 2011). Phosphorylation of tyrosine 397 of FAK results in binding of FAK to 
the SH2 domain of the 85 kDa subunit of PI3K, which can lead to increases in PI3K activity 
(Chen et al. 1996). FAK may modulate mTOR through inhibition of tuberous sclerosis 
complex 2 (TSC2) by phosphorylation, which results ultimately in destabilization and 
proteolytic destruction of TSC2. TSC2 is a negative regulator of mTOR. The first evidence 
for a FAK/TSC2 interaction came from studies of 293T and NIH3T3 cells. These studies 
demonstrated that FAK binds and phosphorylates TSC2 on a residue between 609 and 1080; 
over-expression of a mutant FAK lacking kinase activity decreased phosphorylation of 
p70S6k and eukaryotic 4E-binding protein-1 (4E-BP1) (Gan et al. 2006). This observation 
has been recently reproduced in C2C12 myoblasts; incubation of these cells with IGF-1 
increased FAK autophosphorylation and increased TSC2 phosphorylation as measured by 
Western blotting in cells incubated with scrambled siRNA. Moreover, knockdown of FAK 
expression using FAK-specific siRNA resulted in decreased TSC2 phosphorylation and 
decreased p70S6k and 4E-BP1 phosphorylation and puromycin-labeled nascent polypeptide 
chains compared to scrambled siRNA (Crossland et al. 2013). Conversely, overexpression 
of FAK increased p70S6k phosphorylation independent of Akt activation in rat tibialis 
anterior (Klossner et al. 2009). Consistent with these findings, FAK appears to mediate 
responses in rat skeletal muscle of p70S6K and 4EBP1 to administration of acetaminophen. 
Eight weeks of daily acetaminophen administration leads to a threefold greater expression of 
total and phosphorylated FAK and similar changes are seen in the downstream proteins 
p70S6k and 4E-BP1. These changes affected only the soleus and not the gastrocnemius, 
suggesting that acetaminophen may increase hypertrophic signaling through FAK in a 
muscle/fiber-type dependent manner (Graham, in review).
FAK appears to have a role in the control of energy metabolism and glucose uptake within 
skeletal muscle through insulin and PI3K signaling. Adenovirus delivered anti-sense FAK 
blunts glucose uptake, insulin-stimulated GLUT-4 translocation and glycogen synthesis in 
L6 cells (Huang et al. 2006). Insulin-resistant C2C12 cells have a 40 % decrease in basal 
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FAK phosphorylation and insulin-resistant rats had a roughly 60 % decrease in basal FAK 
phosphorylation with no change in total FAK expression (Bisht et al. 2007). Overexpression 
of FAK increases labeled glucose uptake in insulin-sensitive cells by approximately 40 % 
and insulin-resistant cells by 29 % while overexpression of dominant-negative mutant FAK 
renders wild-type cells insulin-resistant (Bisht et al. 2007). Insulin can initiate actin 
remodeling and colocalization of FAK with remodeled actin which increases the ability of 
GLUT-4 to translocate to the sarcolemma, increasing insulin sensitivity (Bisht and Dey 
2008). Intriguingly, GLUT-4 translocation is blunted by wartmanin, a PI3 K inhibitor, in 
cells over-expressing FAK by preventing actin remodeling, suggesting crosstalk between 
FAK and PI3K in insulin action (Bisht and Dey 2008). Insulin sensitivity can be 
manipulated by changing the phosphorylation state of FAK by known PI3K pathway 
regulators, SHP2 and PTEN. Inhibition of SHP2 and PTEN by siRNA increases FAK 
phosphorylation (Gupta and Dey 2009) and, in C2C12 cells, SHP2 has been found to 
directly bind to FAK, preventing its activity (de Oliveira et al. 2009).
FAK and the response to altered loading
Animal and culture models
FAK is inactivated by cytoskeletal forces (Rahnert and Burkholder 2013). The cellular 
localization of FAK, principally along the cytoplasmic surface of the sarcolemma (Wilson et 
al. 2014, 2012), allows it to be readily available for activation by integrins. While a direct 
link between mechanotransduction-induced FAK activation and muscle hypertrophy is still 
speculative, it has been well established that FAK responds quickly to both overload and 
unloading. Roosters that had their left wings overloaded with 10 % of their body weight for 
1.5 and 7 days had increased FAK expression and increased FAK autophosphorylation at 
tyrosine 397 (Fluck et al. 1999). Further, FAK was observed in the belly of the muscle, 
providing the first evidence that FAK could be localized outside of the myotendinous 
junction (Fluck et al. 1999). Another component of this study used gastrocnemius ablation in 
rats to overload the soleus. The overloaded soleus had increases in FAK expression at 1 and 
8 days post-surgery (Fluck et al. 1999). Gordon et al. (Gordon et al. 2001) used hindlimb 
unloading of female rats to examine the FAK response to changes in muscle loading in 
different muscle groups. The fast twitch plantaris and predominantly fast-twitch 
gastrocnemius had lower baseline levels of FAK expression compared to the soleus and had 
lower FAK expression following 7 days of unloading while the soleus surprisingly increased 
its expression of total FAK. The soleus, but not the plantaris or gastrocnemius, had 
decreases in levels of FAK phosphorylation compared to control rats after unloading 
(Gordon et al. 2001). In parallel studies, the effects of muscle overloading achieved by 
gastrocnemius ablation were examined; the soleus had increases in autophosphorylated FAK 
at 1 and 8 days post-surgery. The plantaris had increases in total FAK expression both 1 and 
8 days post-overload but only had increases in expression of phosphorylated FAK at 8 days 
post-surgery (Gordon et al. 2001). Recently, Klossner et al (Klossner et al. 2013) used 
multiple experiments to analyze the time course of alterations in FAK activation response in 
muscle loading. Increased FAK phosphorylation occurred quickly, within 20 s after a 2 s 
passive stretch of the soleus. Soleus overloading by gastrocnemius ablation increased FAK 
activation at 1 and 24 h post-surgery and total FAK expression 6 and 24 h post-surgery. 
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FAK overexpression increased expression of the costamere-related proteins β1 integrin and 
vinculin following reloading and this response was ablated in the presence of a FAK 
inhibitor, FAK-related non-kinase (FRNK), providing support that FAK expression is 
necessary for load-induced costamere organization (Klossner et al. 2013). We have found 
that total and phosphorylated FAK are lower following 90 min of muscle damage-inducing 
downhill treadmill exercise in the rat soleus compared to non-exercised controls. This 
decrease was seen at 2 h post-exercise but not 48 h post-exercise (Graham et al. 2015). In 
C2C12 cells, 30 min of static stretch decreases phosphorylated FAK by roughly 50 % while 
FAK phosphorylation was not altered in isolated primary muscle fibers from control or γ-
sarcoglycan knockout mice over the course of 4 h of static stretching (Moorwood et al. 
2014). In proliferating C2C12 cells, cyclic strain activates FAK 15 min post-strain, followed 
by a return to baseline at 30 min post-strain (Kumar et al. 2004).
Human models
Muscular unloading can lead to skeletal muscle protein catabolism as soon as 3 days after 
unloading in the vastus lateralis (Tesch et al. 2008). This duration of unloading does not 
alter FAK mRNA levels or total FAK in the vastus lateralis or soleus (Fluck et al. 2014a) 
but does decrease phosphorylation of tyrosine 397 in the vastus lateralis (Fluck et al. 2014a). 
During a 21 day unloading period of the vastus lateralis, FAK phosphorylation was reduced 
at day 10, with no further change seen during the final 11 days of the study. This pattern 
matched well with the overall reduced myofibrillar synthesis rates of the subjects (de Boer et 
al. 2007). In a similar study, 14 days of knee brace unloading resulted in decreases in FAK 
phosphorylation. Furthermore, amino acid supplementation had no effect on FAK 
phosphorylation, although phosphorylation of proteins in the PI3K cascade were increased 
(Glover et al. 2008b). Unloading from extended bedrest led to decreased total FAK 
expression after 8 and 34 days of bedrest with no changes in FAK phosphorylation (Li et al. 
2013). Muscle type may influence the response of FAK during unloading. In a 58 days 
bedrest study using resistance training or resistance training plus vibration training, there 
was no effect on FAK expression in the soleus of the control group or either exercise group. 
However, FAK expression did increase in the vastus lateralis of the control and resistance-
training plus vibration group (Salanova et al. 2014).
Externally applied pressure to muscle is another mechanism for FAK activation. Manual 
massage treatment conducted at the conclusion of a bout of aerobic exercise to exhaustion 
increased FAK phosphorylation in the vastus lateralis immediately post-exercise with a 
return to baseline 3 h later (Crane et al. 2012). We saw no changes in total or phosphorylated 
FAK levels 24, 48, or 72 h after instrument-assisted massage of the gastrocnemius (Graham, 
in review), suggesting that FAK activation in response to massage is most likely transient 
and occurs within the 3 h window.
Traditional exercise, both aerobic and resistance training, are widely used interventions to 
increase muscle health and performance but generally provide for less force production than 
experimental overloading conditions. However, both can transmit forces across the 
sarcolemma and have the potential to activate FAK. Four sets of 10 repetitions of leg press 
and leg extensions maneuvers did not result in changes in FAK phosphorylation in actively 
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resistance-trained men (Glover et al. 2008a). Another study in sedentary males saw that 
FAK phosphorylation was increased for both acute aerobic and anaerobic exercise 
immediately post-exercise with anaerobic exercise remaining elevated at 4 h post-exercise. 
Additionally, 10 weeks of training increased basal levels of FAK phosphorylation 
(Wilkinson et al. 2008). Nine weeks of resistance training (three times a week) on a flywheel 
ergometer that loads the muscle during the concentric and eccentric phases increased 
phosphorylated FAK at both the mid and end of the protocol (Li et al. 2013). Downhill 
skiing training has been shown to increase FAK expression by approximately twofold in 
elderly men while having no effect on elderly women (Flueck et al. 2011).
FAK and clinical conditions
Pathologies such as muscular dystrophies result in satellite activation and increased 
myoblast differentiation in an attempt at muscle regeneration. Dystrophic mice that have 
mutations of the α2 chain of laminins have similar levels of total FAK compared to wild-
type mice 2 weeks after birth. At 12 weeks post-birth, dystrophic mice have a non-
significant 25 % decrease in total FAK in the gastrocnemius and a significant 60 % decrease 
in the rectus femoris (Sakuma et al. 2004). The rectus femoris is not a major weight bearing 
muscle as compared to the gastrocnemius. Furthermore, these dystrophic mice drag their 
hindlimbs by a few weeks after birth and this abnormality progresses to complete hindlimb 
extension after 1–2 months (Sakuma et al. 2004). Thus, the decreases in FAK expression in 
these muscle dystrophy models may be a result of decreased physical activity and muscle 
recruitment.
SCI leads to immobilization and disruption of motor, sensory and autonomic nervous system 
function below the anatomical level of the lesion, creating a state of muscle atrophy that is 
distinct from that of hindlimb suspension in rodents or braces, bedrest and casts in humans. 
The alterations in signaling by FAK after SCI has only recently been investigated. These 
data suggest that individuals who are on average 22 years post-SCI have an approximately 
threefold elevation in phosphorylated FAK compared to able bodied subjects but no further 
increases in FAK activation following external electrical stimulation (Yarar-Fisher et al. 
2014). Conversely, in rat gastrocnemius muscle at 56 days after spinal cord transection we 
have observed that total and phosphorylated FAK are reduced (Graham, manuscript in 
review).
Ischemic protection through FAK
In rats exposed to 4 h of complete femoral artery occlusion, total FAK was increased in the 
gastrocnemius, but not the soleus, 24 h post-reperfusion (Fluck et al. 2014b). FAK 
overexpression prevented ischemic rhabdomyolysis and reduced expression of the 
mitochondrial pore opening protein Bax and inflammatory marker CD68 in the 
predominantly fast-twitch tibialis anterior. In these studies, overexpression of FAK was less 
effective in the soleus but, even so, TUNEL-staining for apoptosis was decreased (Fluck et 
al. 2014b).
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Muscle fiber type and FAK expression
There are differences in FAK expression in muscles with different fiber type characteristics, 
with the slow-twitch and fast-twitch oxidative muscle having higher basal levels (Gordon et 
al. 2001). Type I and IIa muscle fibers show the highest sarcolemmal expression of FAK as 
measured by immunohistochemistry (Flück et al. 2002). Additionally, soleus muscle that 
was cross-reinnervated with the extensor digitorum longus (EDL) nerve gradually lost FAK 
expression while EDL muscle cross-reinnervated with the soleus nerve and placed in the 
soleus cavity demonstrated increased FAK expression (Flück et al. 2002). Thus, the changes 
in localization and expression of FAK seem to be indicative of the properties of the 
innervating nerve, with early and minimal recruitment firing patterns of slow-twitch motor 
neurons driving FAK expression.
This neural drive of FAK is interesting in that FAK may be involved in regulating the 
oxidative capacity of the muscle fiber. Electrotransfer of the FAK gene into the soleus 
increased the expression of multiple proteins of the electron transfer chain as well as myosin 
heavy chain 1. Additionally, FAK overexpression was associated with a decrease in myosin 
heavy chain 2A mRNA and protein expression (Durieux et al. 2009). FAK overexpression 
decreased hybrid fiber percentage whereas FRNK, a competitive inhibitor of FAK, increased 
fast twitch fiber percentage (Klossner et al. 2013). However, these FAK-induced changes 
are not seen when the muscle is unloaded (24), indicating that FAK regulates the oxidative 
phenotype only when under load.
Conclusion
The role of FAK in skeletal muscle provides important insight into how myogenesis and 
muscle homeostasis is regulated by integrated responses of multiple signaling pathways. The 
role of FAK is plieotropic, with roles in regulating myogenesis, muscle phenotype, 
costamere formation, muscle hypertrophy and glucose uptake. Developing therapies or 
interventions that take advantage of these many functions of FAK in muscle homeostasis 
may prove to be beneficial for increasing muscle health. The role of FAK in promoting cell 
survival has readily been established in multiple cell types and conditions and information 
gained may provide insights regarding how to design exercise or pharmaceutical 
interventions that help protect against muscle atrophy following SCI or in cachectic and 
sarcopenic conditions.
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Simplified structure, domain roles and important phosphorylation sites of FAK. 
Autoinhibition is a result of interactions between the FERM and kinase domains, which 
prevents autophosphorylation of Y397, the major phosphorylation site of FAK. 
Phosphorylation of Y397 creates strong binding affinities for proteins containing SH2-
domains, mainly cSrc and PI3K. Binding of cSrc induces phosphorylation of Y576/577, 
resulting in FAK’s full activation. In skeletal muscle, the role of major tyrosine and serines 
in the FAT and preceding linker domain remain unknown. Figure based on (Franchini 2012; 
Hanks et al. 2003; Lietha et al. 2007)
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Prominent signaling through the FAK nexus. Either mechanical activation from integrins or 
upstream regulation from growth factor signaling can activate multiple pathways that result 
in protein synthesis and anti-apoptosis. Other factors not shown that may similarly regulate 
FAK are RhoA, neoginin and protein kinase C
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